Courses

The End of Alzheimer's (CHES)

The First Program to Prevent & Reverse Cognitive Decline

This course is only for CHES practitioners.

Dr. Bredesen’s research and clinical experience shows great insight into a disease we have been told is incurable and irreversible. By studying the biology and pathology of Alzheimer’s disease, he has determined there are three risk sub-groups that require and respond to different treatments. This is a fantastic resource for practitioners, their families, and their patients. 

Every citizen and medical professional interested in the brain and its health should read this seminal book. It should provide much of the basis for a true revolution in brain health medicine. Michael Merzenich, PhD, winner of the Kavil Prize in Neuroscience

Choose between two versions:

CHES Program ID # 30195 Max CHES 15 hours / Advanced CHES 7 hours

CHES Program ID # 30196 Max CHES 25 hours / Advanced CHES 7 hours

Course Expiration Date
Jul-31-2021
Grouped product items
Product Name Price Qty
Book Only (1670)
$23.00
15 CE Online Test Only (1671CHES)
$112.00
25 CE Online Test Only (1672CHES)
$132.00
15 CE Book & Online Test (1673CHES)
$130.00
25 CE Book & Online Test (1674CHES)
$150.00

Book Details

Author
Year Published
2017
Edition
1st Edition
Publisher
Avery
ISBN
978-0735216204
Format
Hardback
Page Count
320
Learning Code
  • (2000) Science of food and nutrition
  • (4190) Elderly nutrition
  • (5000) Medical Nutrition Therapy
  • (5100) Elderly
  • (5300) Neurological: stroke, Alzheimer's, dementia, Parkinson's spinal cord injuries
  • (5320) Psychiatric disorders, anxiety

Course Objectives

Choose between two versions:

CHES Program ID # 30195 Max CHES 15 hours / Advanced CHES 7 hours

CHES Program ID # 30196 Max CHES 25 hours / Advanced CHES 7 hours

CHES Competencies:

1.2.3 Review related research

1.4 Analyze relationships among behavioral, environmental and other factors that influence health

1.4.2 Identify and analyze factors that impact health

1.7.2 Identify current needs, resources, and capacity

7.2.1 Identify current and emerging issues requiring advocacy       

Advanced Competency:

2.3.2 Assess efficacy of various strategies/interventions to ensure consistency with objectives

2.3.3 Apply principles of evidence-based practice in selecting and/or designing strategies/interventions

Upon successful completion, the users will be able to: 

1. List five known triggers or toxins that may contribute to the development of Alzheimer’s.

2. Identify the three different types of Alzheimer’s and what distinguishes each.

3. Explain the function of amyloid that the author believes is different than we have formerly believed.

4. Discuss how chronically high levels of inflammation or insulin can affect the risk of Alzheimer’s.


Recommended For...
Certified Health Education Specialist (CHES)
Why we chose this book

This highly qualified researcher has organized his extensive information, clinical experience, patient outcomes, and evidence-based research into readable, interesting, hopeful text that readers love. Our reviewers said it was one of their favorite books. 

About the author

Dr. Dale Bredesenis an internationally recognized expert in the mechanisms of neurodegenerative diseases like Alzheimer’s. He has served as chief resident in neurology at the University of California, San Francisco, a NIH postdoctoral Fellow in Nobel laureate Stanley Prusiner’s laboratory, faculty positions at UCSF, UCLA, and University of California, San Diego. Since 1998, he has been the founding president and CEO of Buck Institute where he is the chief medical officer of MPI Cognition.